About Rupesh Kotecha
Pleural and Lung Cancer
Excellence in Research
Board Certified in Radiation Oncology
10+ Years of Experience
Dr. Rupesh Kotecha has the training and experience in utilizing the latest radiation technology, including state-of-the-art pencil-beam proton therapy that was added recently at the Miami Cancer Institute and is changing the way patients are treated.
He also has taken leadership in the use of the innovative Tumor Treating Fields, the non-invasive therapy that utilizes low-voltage electric fields and works by disrupting cancer cell division.
The U.S. Food and Drug Administration approved the use of Tumor Treating Fields for mesothelioma in 2019, the first new treatment approved for this aggressive cancer in more than 15 years.
“It’s something we can now offer patients that has shown a real benefit,” he said. “If we can deliver therapy that helps control this disease, and not put patients at risk, that is exciting for us.”
Pioneer in TTFields for Mesothelioma
Kotecha was one of the first in America to use TTFields for mesothelioma under the FDA’s Humanitarian Device Exemption Protocol.
His previous experience in using the therapy successfully with glioblastoma, an aggressive form of brain cancer, played a role in the quick approval at the Miami Cancer Institute.
“It [Tumor Treating Fields] has been a game changer with glioblastoma. I can’t say that yet with mesothelioma because we don’t have that level of data, but we’re encouraged by the data we have,” he said. “It’s another tool in our armamentarium.”
Expertise in Stereotactic Radiosurgery
Kotecha also has a special interest in stereotactic radiosurgery in the management of brain metastases that has improved patients’ quality of life.
His use of pencil-beam proton therapy has changed the way pleural mesothelioma patients are being treated in Miami.
It has allowed him to be more exact in mesothelioma treatment, pinpointing tumor cells while minimizing radiation exposure to healthy tissues and organs. There are fewer short-term and long-term side effects.
“We have here, basically any technology available to cancer patients in the world,” he said. “For each patient who comes to me, I can do an individualized treatment plan for that patient, with any machine on the market.”
Kotecha, who followed in his father’s medical-background footsteps, also is known for his patient-centered manner at the Miami Cancer Institute. He graduated from the Michigan State University Medical School and completed his residency at the Cleveland Clinic.
“I want patients to know as much about their cancer as I know, whether that takes 20 minutes, an hour, or three hours,” he said. “I want them to walk away feeling empowered and educated about the process.”
Disclaimer: Dr. Rupesh Kotecha has no professional affiliation with Asbestos.com.
1 Cited Article Sources
The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.
- Miami Cancer Institute Baptist Health Florida. (n.d.). About Rupesh Rajesh Kotecha. Retrieve from Retrieved from: https://pmc-baptist-cancer.provider-match.com/provider/Rupesh+Rajesh+Kotecha/870296
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?
Share this article
Last Modified December 17, 2019